Efficacy of Ertapenem for Treatment of Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae

Ertapenem is active against extended-spectrum-β-lactamase (ESBL)-producing Enterobacteriaceae organisms but inactive against Pseudomonas aeruginosa and Acinetobacter baumannii. Due to a lack of therapeutic data for ertapenem in the treatment of ESBL bloodstream infections (BSIs), group 2 carbapenems...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Collins, Vicki L., Marchaim, Dror, Pogue, Jason M., Moshos, Judy, Bheemreddy, Suchitha, Sunkara, Bharath, Shallal, Alex, Chugh, Neelu, Eiseler, Sara, Bhargava, Pragati, Blunden, Christopher, Lephart, Paul R., Memon, Babar Irfan, Hayakawa, Kayoko, Abreu-Lanfranco, Odaliz, Chopra, Teena, Munoz-Price, L. Silvia, Carmeli, Yehuda, Kaye, Keith S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2012
Soggetti:
Clinical Therapeutics
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3318320/
https://ncbi.nlm.nih.gov/pubmed/22290982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.05913-11
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi